Dr. Paul Leva, MD

NPI: 1841222577
Total Payments
$14,754
2024 Payments
$2,159
Companies
53
Transactions
640
Medicare Patients
4,248
Medicare Billing
$449,194

Payment Breakdown by Category

Food & Beverage$14,326 (97.1%)
Travel$380.71 (2.6%)
Education$46.67 (0.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $14,326 629 97.1%
Travel and Lodging $380.71 5 2.6%
Education $46.67 6 0.3%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $3,545 175 $0 (2024)
Amgen Inc. $1,385 50 $0 (2024)
Amarin Pharma Inc. $1,303 58 $0 (2023)
Novo Nordisk Inc $1,105 41 $0 (2024)
Apyx Medical Corporation $1,030 16 $0 (2020)
Merck Sharp & Dohme LLC $645.34 31 $0 (2023)
Lilly USA, LLC $606.73 31 $0 (2024)
Janssen Pharmaceuticals, Inc $572.04 30 $0 (2024)
GlaxoSmithKline, LLC. $515.65 29 $0 (2024)
Sumitomo Pharma America, Inc. $464.47 9 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,159 73 AstraZeneca Pharmaceuticals LP ($791.10)
2023 $1,872 81 AstraZeneca Pharmaceuticals LP ($421.50)
2022 $2,046 81 AstraZeneca Pharmaceuticals LP ($429.79)
2021 $1,661 88 Amarin Pharma Inc. ($301.28)
2020 $1,314 67 AstraZeneca Pharmaceuticals LP ($426.49)
2019 $1,677 73 AstraZeneca Pharmaceuticals LP ($330.77)
2018 $2,615 98 Apyx Medical Corporation ($671.24)
2017 $1,409 79 AstraZeneca Pharmaceuticals LP ($345.20)

All Payment Transactions

640 individual payment records from CMS Open Payments — Page 1 of 26

Date Company Product Nature Form Amount Type
12/16/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.58 General
Category: Respiratory
12/13/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $25.44 General
Category: UROLOGY
12/12/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $24.62 General
Category: Cardiovascular and Metabolism
12/05/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $21.57 General
Category: Inflammation
12/04/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $23.07 General
Category: Diabetes
11/21/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.56 General
Category: RESPIRATORY
11/20/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $21.41 General
Category: Cardiovascular and Metabolism
11/06/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.96 General
Category: Diabetes
11/06/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $10.94 General
Category: UROLOGY
11/01/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $28.83 General
Category: UROLOGY
10/30/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $21.75 General
Category: Respiratory
10/24/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $125.01 General
Category: Obesity
10/24/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $22.25 General
Category: VACCINES
10/24/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $21.68 General
Category: Respiratory
10/17/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $27.20 General
Category: Obesity
10/16/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $23.48 General
Category: Diabetes
10/10/2024 Verity Pharmaceuticals Inc. Tlando (Drug) Food and Beverage Cash or cash equivalent $48.46 General
Category: Testosterone Replacement Therapy (TRT)
10/08/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $19.95 General
Category: Cardiovascular and Metabolism
10/02/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $26.55 General
Category: Cardiovascular and Metabolism
09/26/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $31.36 General
Category: Cardiovascular and Metabolism
09/25/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $117.77 General
Category: Obesity
09/24/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $24.35 General
Category: Respiratory
09/11/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $22.10 General
Category: Respiratory
09/11/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $20.59 General
Category: Diabetes
09/10/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $19.26 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 938 1,613 $181,415 $108,646
2022 11 1,066 1,801 $197,565 $122,881
2021 14 1,156 1,939 $196,660 $121,876
2020 13 1,088 1,963 $199,975 $95,792
Total Patients
4,248
Total Services
7,316
Medicare Billing
$449,194
Procedure Codes
50

All Medicare Procedures & Services

50 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 201 611 $76,375 $48,278 63.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 166 250 $50,100 $27,546 55.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 64 64 $11,520 $9,531 82.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 90 168 $15,120 $8,019 53.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 34 42 $12,600 $6,812 54.1%
36415 Insertion of needle into vein for collection of blood sample Office 2023 160 251 $3,765 $2,108 56.0%
G0442 Annual alcohol misuse screening, 5 to 15 minutes Office 2023 73 73 $2,920 $1,574 53.9%
11980 Placement of hormone pellet under skin Office 2023 13 17 $2,550 $1,502 58.9%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 66 66 $1,980 $1,423 71.9%
G0008 Administration of influenza virus vaccine Office 2023 22 22 $1,055 $791.56 75.0%
90662 Influenza vaccine split virus, preservative free Office 2023 12 12 $600.00 $588.00 98.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 37 37 $2,830 $472.15 16.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 199 661 $82,625 $52,929 64.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 164 250 $50,000 $28,840 57.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 109 109 $19,620 $16,984 86.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 119 190 $17,100 $9,331 54.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 24 35 $10,500 $6,134 58.4%
G0442 Annual alcohol misuse screening, 15 minutes Office 2022 117 117 $4,680 $2,654 56.7%
G0444 Annual depression screening, 15 minutes Office 2022 118 118 $3,540 $2,627 74.2%
11980 Placement of hormone pellet under skin Office 2022 12 19 $2,850 $1,658 58.2%
36415 Insertion of needle into vein for collection of blood sample Office 2022 163 258 $3,870 $763.98 19.7%
G0008 Administration of influenza virus vaccine Office 2022 16 17 $890.00 $601.73 67.6%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 25 27 $1,890 $358.29 19.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 186 521 $65,125 $44,337 68.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 169 262 $52,400 $29,885 57.0%

About Dr. Paul Leva, MD

Dr. Paul Leva, MD is a Internal Medicine healthcare provider based in Northport, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841222577.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Leva, MD has received a total of $14,754 in payments from pharmaceutical and medical device companies, with $2,159 received in 2024. These payments were reported across 640 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($14,326).

As a Medicare-enrolled provider, Leva has provided services to 4,248 Medicare beneficiaries, totaling 7,316 services with total Medicare billing of $449,194. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Northport, NY
  • Active Since 07/06/2006
  • Last Updated 12/17/2007
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1841222577

Products in Payments

  • FARXIGA (Drug) $2,299
  • Vascepa (Drug) $1,303
  • Otezla (Drug) $555.60
  • XARELTO (Drug) $554.44
  • Repatha (Biological) $499.42
  • TRELEGY ELLIPTA (Drug) $486.23
  • GEMTESA (Drug) $464.47
  • BREZTRI (Drug) $435.41
  • Wegovy (Drug) $433.21
  • AIRSUPRA (Drug) $420.94
  • Livalo (Drug) $269.79
  • SYMBICORT (Drug) $247.75
  • JANUVIA (Drug) $239.02
  • Ozempic (Drug) $233.08
  • General - Pain Management (Device) $205.67
  • Rybelsus (Drug) $200.71
  • TRULICITY (Drug) $167.98
  • Xeomin (Biological) $158.29
  • Dayvigo (Drug) $157.60
  • LEQVIO (Drug) $151.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Northport